Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04688736
PHASE2

Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions.

Sponsor: Institute of Hematology & Blood Diseases Hospital, China

View on ClinicalTrials.gov

Summary

This is a prospective, randomized, double-blind controlled trial to evaluate the efficacy of placebo versus chlorpheniramine for the prevention of allergic transfusion reactions.

Official title: A Prospective, Randomized, Double-blind Controlled Trial of Chlorpheniramine Pretransfusion Medication for Allergic Transfusion Reactions

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

6642

Start Date

2021-01-01

Completion Date

2027-06-30

Last Updated

2025-08-05

Healthy Volunteers

No

Interventions

DRUG

Placebo

The tablet resembles chlorpheniramine but has no therapeutic value.

DRUG

Chlorpheniramine

An antihistamine that reduces the natural chemical histamine in the body.

Locations (4)

Anhui Provincial Hospital

Hefei, Anhui, China

Zhoukou Central Hospital

Zhoukou, Henan, China

The Second Affilated Hospital of Shandong First Medical University

Tai’an, Shandong, China

Regenerative Medicine Center

Tianjin, Tianjin Municipality, China